Skip to main content
DH
NASDAQ Technology

Advent Proposes $1.02/Share Buyout of Definitive Healthcare — 36% Premium

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.89
Mkt Cap
$130.689M
52W Low
$0.61
52W High
$4.35
52W Position info
46% above low
Off High info
80% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

DH sits 46% above its 52-week low of $0.61.

Summary

Advent International, which already owns 58.54% of Definitive Healthcare, has proposed to acquire all remaining shares for $1.02 per share in cash — a 36% premium to the 60-day VWAP. The non-binding proposal is not subject to financing conditions and is premised on founder Jason Krantz rolling over his equity. The Special Committee confirmed receipt and will review the proposal with independent advisors; no stockholder action is required at this time.

Updated with an SEC 8-K filing · What changed

Updates

  1. · Dow Jones Newswires — Shares jumped 14% to $1.03 in premarket trading after the offer. A special committee of independent directors has been formed to evaluate the proposal.

  2. · SEC 8-K — The Special Committee has engaged Rothschild & Co and Skadden as advisors to review Advent's proposal.

    • Proposal Terms — Advent proposes to acquire all outstanding Class A common stock and Definitive OpCo Units not already owned by Advent or Jason Krantz for $1.02 per share and an equivalent amount per unit.
    • Advisors — Rothschild & Co and Skadden, Arps, Slate, Meagher & Flom LLP are advising the Special Committee; Evercore and Hogan Lovells Cadwalader are advising the Company.
    • Announcement Date — The company announced the proposal on September 2, 2026.
    All 7 details
    • The proposal is to acquire all outstanding shares of Class A common stock and all outstanding limited liability company interests of AIDH TopCo, LLC (Definitive OpCo Units) not already owned by Advent or Jason Krantz.
    • The purchase price is $1.02 per share of Class A common stock and an equivalent amount per Definitive OpCo Unit.
    • Rothschild & Co is serving as financial advisor to the Special Committee.
    • Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel to the Special Committee.
    • Evercore is serving as financial advisor to the Company.
    • Hogan Lovells Cadwalader is serving as legal counsel to the Company.
    • The company announced the proposal on September 2, 2026.

Key Events · M&A and Partnerships · DH

  • New · · SEC 8-K

    Advisors to Special Committee and Company

    Rothschild & Co is serving as financial advisor to the Special Committee, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel to the Special Committee. Evercore is serving as financial advisor to the Company, and Hogan Lovells Cadwalader is serving as legal counsel to the Company.

  • New · · SEC 8-K

    Proposal Announced

    The company announced the proposal on September 2, 2026.

  • Updated · · SEC 8-K

    Advent Proposes $1.02/Share Buyout of Class A and OpCo Units

    Advent International submitted a non-binding proposal on September 1, 2026 to acquire all outstanding shares of Class A common stock and all outstanding limited liability company interests of AIDH TopCo, LLC (Definitive OpCo Units) not already owned by Advent or Jason Krantz for $1.02 per share of Class A common stock and an equivalent amount per Definitive OpCo Unit in cash.

  • Updated · · SEC 8-K

    Special Committee Confirms Receipt and Review

    The Special Committee confirmed receipt of Advent's non-binding proposal and will review it with independent advisors; no stockholder action is required at this time. The proposal is non-binding and subject to approval by the Special Committee of independent directors, negotiation of definitive agreements, and customary closing conditions.

  • 36% Premium to 60-Day VWAP

    The $1.02 offer price represents a 36% premium to the 60-day volume-weighted average trading price of $0.75 per share as of August 31, 2026.

  • No Financing Condition

    The proposal is not subject to any financing condition, and Advent states it does not anticipate substantial regulatory hurdles or delays.


Analysis · DH · Technology

Advent International, already the controlling shareholder with 58.54% of Definitive Healthcare, has submitted a non-binding proposal to acquire all outstanding shares of Class A common stock and all outstanding limited liability company interests of AIDH TopCo, LLC (Definitive OpCo Units) not already owned by Advent or Jason Krantz for $1.02 per share of Class A common stock and an equivalent amount per Definitive OpCo Unit in cash. The offer represents a 36% premium to the 60-day VWAP of $0.75 as of August 31, 2026, and is not subject to any financing condition. The proposal is premised on founder and Executive Chairman Jason Krantz rolling over his equity into the surviving company. The Special Committee has confirmed receipt of the proposal and will review it with independent advisors; no stockholder action is required at this time. Rothschild & Co is serving as financial advisor to the Special Committee, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel to the Special Committee. Evercore is serving as financial advisor to the Company, and Hogan Lovells Cadwalader is serving as legal counsel to the Company. The company announced the proposal on September 2, 2026. This is a significant development for a company that received a Nasdaq delisting notice in June 2026 and reported declining revenue in Q2 2026. The proposal provides minority shareholders with an immediate liquidity opportunity at a substantial premium to recent trading levels, though it remains non-binding and subject to Special Committee approval and negotiation of definitive agreements.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51% of the 202 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.71%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DH was trading at $0.89 on NASDAQ in the Technology sector, with a market capitalization of approximately $130.7M. The 52-week trading range was $0.61 to $4.35. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DH - Latest Insights

DH
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.15 info
Change: +$0.020 (+2%) info
Market Cap: $163.668M info
DH
Oct 01, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.9361
Real-time Price: $1.15 info
Change: +$0.2139 (+23%) info
Market Cap: $163.668M info
DH
Sep 09, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $1.15 info
Change: +$0.120 (+12%) info
Market Cap: $163.668M info
DH
Sep 02, 2026, 9:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.15 info
Change: +$0.100 (+10%) info
Market Cap: $163.668M info
DH
Sep 02, 2026, 8:40 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $1.15 info
Change: +$0.140 (+14%) info
Market Cap: $163.668M info